COLELLA, ELISA

COLELLA, ELISA  

Universita' degli Studi di MILANO  

Risultati 1 - 17 di 17 (tempo di esecuzione: 0.003 secondi).
Titolo Data di pubblicazione Autore(i) Tipo File Abstract
96-week results of a dual therapy with darunavir/ritonavir plus rilpivirine once a day vs triple therapy in patients with suppressed viraemia: virological success and non-HIV related morbidity evaluation 2-gen-2020 Di Cristo, ValentinaVitiello, PaolaCossu, Maria VittoriaColella, ElisaRusconi, Stefano + Article (author) -
ACE inhibitors and ribavirin-associated cough: a common undefined predisposing factor? 1-gen-2013 D. CattaneoS. CheliL. FerrarisE. ColellaE.G.I. Clementi + Article (author) -
The contribution of immune activation and accelerated aging in multiple myeloma occurring in HIV-infected population 1-gen-2018 Bandera, AlessandraColella, ElisaClerici, MarioGori, Andrea + Article (author) -
Darunavir-cobicistat-emtricitabine-tenofovir alafenamide: safety and efficacy of a protease inhibitor in the modern era 1-gen-2018 Bozzi, GiorgioColella, ElisaGori, AndreaBandera, Alessandra + Article (author) -
Effectiveness, durability, and safety of darunavir/ritonavir in HIV-1-infected patients in routine clinical practice in Italy : A postauthorization noninterventional study 6-mag-2016 A. D. MonforteS. RusconiE. Colella + Article (author) -
Efficacy, tolerability and virological consequences of long-term use of unboosted atazanavir plus 2 NRTIs in HIV-infected patients 1-nov-2014 O. ViganoE. ColellaM. GalliS. Rusconi + Article (author) -
Factors involved in continuance of atazanavir-based regimens : Results from a cohort of HIV1-positive patients 20-feb-2016 A. GiacomelliM. FranzettiV. Di CristoE. ColellaM. GalliS. Rusconi + Article (author) -
Factors involved in treatment durability and immunological recovery in a cohort of HIV-positive patients receiving atazanavir-based regimens 2-nov-2014 A. GiacomelliM. FranzettiV. Di CristoB. VerganiMOROSI, MANUELAE. ColellaM. GalliS. Rusconi + Article (author) -
Hepatitis C virus-related factors associated WITH cognitive performance in HIV-HCV-coinfected patients 7-lug-2019 Colella, ElisaGori, AndreaBandera, Alessandra + Article (author) -
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting 1-gen-2021 Lombardi A.D'Ambrosio R.Degasperi E.Dibenedetto C.Giorgini A.Pasulo L.Spinelli O.Re T.Rumi M.Aghemo A.Lampertico P.Soffredini R.Perbellini R.Gori A.Colpani M.Manini M.Lazzaroni S.De Nicola S.Angelini Zucchetti T.Rossotti R.Colella E.Magnani C.Mena M.Caramma I.Basilico C.Biagiotti S.Mazzone A.Saladino V.Menzaghi B.Rumi M.Fanetti I.Dibenedetto C.Zermiani P.Zuin M.D'Arminio Monforte A.Capretti A.Messina E.Colombo A. E.Bonfanti P.Conforti S.Menozzi F.Gritti S.Giani P. + Article (author) -
Integrase inhibitors use and CMV infection predict immune recovery in peolple living with HIV starting first-line therapy 1-gen-2020 Taramasso, LuciaLombardi, AndreaColella, ElisaGori, AndreaBandera, Alessandra + Article (author) -
Maraviroc : un inibitore del co-recettore CCR5 con un unico profilo di efficacia e tollerabilita’ in diversi scenari clinici dell'infezione da HIV-1 1-set-2012 S. RusconiE. ColellaP. Vitiello Article (author) -
Maraviroc as Intensification Strategy in HIV-1 Positive Patients with Deficient Immunological Response: an Italian Randomized Clinical Trial 14-nov-2013 S. RusconiP. VitielloE. ColellaA. CapettiF. BaiM. MorosiP. TauE. MerliniG. Marchetti + Article (author) -
Maraviroc intensification for HIV-1-positive immunological non-responders (INRs) despite virological suppression during HAART 8-nov-2010 S. RusconiP. VitielloE. ColellaE. MerliniG.C. Marchetti + Article (author) -
Potential associations between atazanavir exposure and clinical outcome: a pharmacokinetic sub-study from the MODAt randomized trial 2-mar-2018 Colella, ElisaCattaneo, DarioGalli, LauraBaldelli, SaraClementi, EmilioGalli, MassimoLazzarin, AdrianoRusconi, Stefano + Article (author) -
Predictive factors of therapeutic success of a HAART regimen including atazanavir with or without ritonavir in HIV-infected patients 11-nov-2012 A. GiacomelliM. FranzettiB. VerganiM. MorosiV. Di CristoE. ColellaO. ViganòM. GalliS. Rusconi + Article (author) -
Treatment outcome in HIV+ patients receiving 3- or 4-drug regimens during PHI 2-nov-2014 P. TauE. ColellaV. MicheliM. GalliS. Rusconi + Article (author) -